Coupa Software Reports First Quarter Fiscal 2023 Financial Results
/PRNewswire/ -- Coupa Software (NASDAQ: COUP) today announced financial results for its first fiscal quarter ended April 30, 2022....
Source: prnewswire.com
📰 Escape Bio News
Escape Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Escape Bio. Real-time updates on events, politics, business and more.
UC Davis, UC CoM Identify Key Regulatory Mechanism in Inflammation
UC News about Entomology and Nematology.
United States University Of Cincinnati San Francisco Kathy Keatley Garvey Kathy Keatley Garvey Co Lead Christian Bergmann
Source: ucanr.edu
Another $80M: mRNA biotech ReCode matches 2020 series A with Pfizer, Sanofi money for cystic fibrosis trial
ReCode Therapeutics is back with its second $80 million financing round, this time a series B from Pfizer, Sanofi and VC shops, to bring its lead programs into human trials. Up first are cystic fibrosis and primary ciliary dyskinesia, another lung disease.
Source: fiercebiotech.com
Chutes & Ladders—FDA's vaccine office gets new leader as 2 officials head toward exit
FDA's vaccines office is now headed by Peter Marks after the agency's top two vaccine officials questioned the need for booster doses last month as they head toward the exit later this fall. Houston biotech incubator Sporos Biosciences snagged ex-Ovid Therapeutics Chief Medical Officer Amit Rakhit as its new CEO. In spinning off its gene therapy unit, Amicus' CEO will head to the new company being launched via a SPAC.
Source: fiercebiotech.com